Crossmark

Immune checkpoint inhibitor-related type 1 diabetes mellitus with closely monitored dynamics of glutamic acid decarboxylase antibody levels before and after disease onset

Crossref DOI link: https://doi.org/10.1007/s13340-025-00795-0

Published Online: 2025-02-10

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sakaue, Taka-aki

Obata, Yoshinari https://orcid.org/0000-0002-3443-3635
Sakai, Kumiko

Onishi, Ayano

Mukai, Kosuke

Miyashita, Kazuyuki

Kozawa, Junji

Nishizawa, Hitoshi

Shimomura, Iichiro
License Information

Text and Data Mining valid from 2025-02-10

Version of Record valid from 2025-02-10
More Information

Article History

Received: 20 November 2024

Accepted: 15 January 2025

First Online: 10 February 2025

Declarations

:

: The authors declare no conflicts of interest.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

Document is current

Any future updates will be listed below